NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
42 hedge funds and large institutions have $14.2M invested in Niagen Bioscience, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-4
Holders Change %
-8.7%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
12
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$366K |
2 |
VF
Virtu Financial
New York
|
+$272K |
3 |
PHS
Pekin Hardy Strauss
Chicago,
Illinois
|
+$150K |
4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$128K |
5 |
UBS Group
Zurich,
Switzerland
|
+$93.6K |